Research Center: Wellington Regional Hospital
Location: 49 Riddiford Street, Newtown, Wellington 6021, New Zealand
Lead Researcher: Prof. Jeremy Krebs
Ethics Committee: This study has been reviewed and approved by the Central Ethics Committee
Pre-diabetes is a condition wherein blood sugar levels are slightly higher than normal but not high enough to be considered Diabetes. Diabetes is a condition wherein blood sugar levels are above the normal range. These conditions may be managed by lifestyle or medication.
Researchers are exploring natural alternatives that may help manage Pre-diabetes and Diabetes. This study seeks to explore the effectiveness of the Dahlia plant’s flower extract as a new potential treatment for Pre-diabetes and Diabetes. Researchers also want to determine the best way (including dosage) to use the flower extract of the Dahlia plant that would benefit those with Pre-diabetes and Diabetes.
This study is looking for men aged 18 years old and above who have either Pre-diabetes or Type 2 Diabetes. Interested participants must be managing their condition through lifestyle changes or by taking Metformin as their medication. Participants must be willing to comply with all the study requirements.
- You may experience improvements to your pre-diabetes or diabetes.
- You may receive a new potential natural alternative that may help manage your symptoms.
- You may contribute valuable information that may benefit others in the future.
- You will be compensated up to $150 for participating in this study.
- You will be helping to advance medical research.
- If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
- Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
- Qualified health professionals will monitor your health as it relates to the study.
Who Can Participate?
- Men aged 18 years old or older who have either Pre-diabetes or Type 2 Diabetes.
- Participants must be managing their condition either through lifestyle changes or Metformin. Metformin is a medication for Diabetes.
- Participants must be able to attend 3 study visits as well as comply with the following study requirements at the research site for over approximately 4 weeks:
- Participants must be willing to take the potential treatment (in capsule form) as instructed by the study team.
- Participants must be willing to comply with all the study-related assessments, procedures and follow a specific diet as instructed by the study team.
About The Research Center:
Wellington Regional Hospital
Wellington Hospital, also known as Wellington Regional Hospital, is the main hospital in Wellington, New Zealand, located south of the city centre in the suburb of Newtown. It is the main hospital run by Capital & Coast District Health Board (C&CDHB), which serves Wellington City, Porirua and the Kapiti Coast District.
Due to the current situation with COVID-19 pandemic, the study team would like to point out the following:
- The research site’s waiting area is spacious enough that participants will not be within close proximity to each other.
- Hand sanitisers are available at the research site.
- The research staff adheres to strict hygienic practices as well as other safety measures to prevent the spread of COVID-19.
- Any staff suspected to have COVID-19, or has come into contact with someone who has COVID-19, will automatically undergo a voluntary quarantine for 14 days.
- Interested participants will not be left waiting for a long period of time and will be quickly attended to.
- Parking is available at the research site.
- The research site/institution is taking all precautionary measures to ensure the safety of the study participants.